AMZN
Amazon.com, Inc.
AMZN has the edge over JMIA overall, supported by lower modeled downside and stronger valuation.
JMIA
Jumia Technologies AG
JMIA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
JMIA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
JMIA's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
JMIA PE Valuation
JMIA has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
JMIA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect JMIA's losses to shrink, with revenue growing.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over JMIA on earnings quality, reporting a profit while its opponent remains loss making.
JMIA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.94 | +$0.08 |
| Q1 2026 | -$1.03 | -$0.07 |
| Q4 2025 | -$1.03 | +$0.05 |
| Q3 2025 | -$1.18 | -$0.25 |
| Q2 2025 | -$1.02 | -$0.01 |
| Q1 2025 | -$0.96 | +$0.15 |
| Q4 2024 | -$1.08 | -$0.05 |
| Q3 2024 | -$0.93 | +$0.49 |
JMIA is still losing money, but far less than before: $0.94 per share over the past year, against $3.65 at its worst in late 2019.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over JMIA on profitability, with a higher operating margin.
JMIA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $51.9M | +14% |
| Q1 2026 | $50.6M | +39% |
| Q4 2025 | $61.3M | +34% |
| Q3 2025 | $45.6M | +25% |
| Q2 2025 | $45.6M | +25% |
| Q1 2025 | $36.3M | -26% |
| Q4 2024 | $45.7M | -2.2% |
| Q3 2024 | $36.4M | -13% |
JMIA's revenue is recovering but still below its 2020 peak: $52M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -24% | +12 points |
| Q1 2026 | -27% | +24 points |
| Q4 2025 | -19% | +19 points |
| Q3 2025 | -38% | +17 points |
| Q2 2025 | -36% | +19 points |
| Q1 2025 | -51% | -34 points |
| Q4 2024 | -38% | -37 points |
| Q3 2024 | -55% | -11 points |
JMIA's operating margin was −24% last quarter, up 12 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
JMIA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$12.3M | +$1.1M |
| Q1 2026 | -$13.1M | +$9M |
| Q4 2025 | -$3.4M | +$25M |
| Q3 2025 | -$13.8M | +$13.9M |
| Q2 2025 | -$13.4M | -$4.3M |
| Q1 2025 | -$22M | -620% |
| Q4 2024 | -$28.4M | -$18.3M |
| Q3 2024 | -$27.7M | -$3.3M |
JMIA has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over JMIA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
JMIA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +59K shares |
| 1 year | +1.2% | +754K shares |
| 3 years | -38% | -38.6M shares |
| 5 years | -37% | -36.6M shares |
| Available history | -21% | -16.4M shares |
JMIA has 62M diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $35,034 |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $6,000 |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
JMIA has spent almost nothing on buybacks in the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
JMIA Net Leverage
JMIA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
JMIA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.4 | Neutral |
| Stochastic | 18.2 | Oversold |
JMIA's weekly RSI is 39 (neutral) and its Stochastic is 18 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
JMIA PE vs Consumer Cyclical Sector
JMIA has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over JMIA on trend strength, trading above more of its moving averages.
JMIA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.99 | 6% below |
| 20 week MA | $6.40 | 12% below |
| 50 week MA | $8.05 | 30% below |
| 100 week MA | $6.84 | 18% below |
| 200 week MA | $5.66 | 0.5% below |
JMIA is in a downtrend: it's below all five of its weekly moving averages, and 0.5% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over JMIA on returns for 2026, with the stronger performance.
JMIA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.13 | $43.6 | +612% |
| 2021 | $43.6 | $12.4 | -72% |
| 2022 | $12.4 | $3.21 | -74% |
| 2023 | $3.21 | $3.53 | +10% |
| 2024 | $3.53 | $4.01 | +14% |
| 2025 | $4.01 | $12.0 | +198% |
| 2026 YTD | $12.0 | $5.63 | -53% |
JMIA's yearly returns have swung widely, from +612% in 2020 to −74% in 2022. It's down 53% so far in 2026.